Provider of business intelligence solutions, reducing health care costs and improving quality.

Understanding the business of healthcare requires the ability to integrate point-of-care clinical data with administrative and financial data and to transform that raw data into actionable information. Having access to the right data at the right time helps managers and clinicians support the organization and its patients while improving health care quality performance.

McKesson’s solutions for performance management help identify quality improvement opportunities, reduce practice variability, lower costs, track progress and optimize resources to focus on your organization’s most critical goals.

Learn about a treatment option for metastatic colorectal cancer and an initial treatment option for locally or regionally advanced head and neck cancer.

Colon Cancer:
ERBITUX (Cetuximab) is indicated for the treatment of patients who have colorectal cancer that has spread to other parts of the body and whose tumor expresses a protein called an Epidermal Growth Factor Receptor (EGFR).

Head & Neck Cancer:
ERBITUX (Cetuximab), in combination with radiation therapy, is indicated for the initial treatment of a certain type of locally or regionally advanced head and neck cancer.